Atypical Pathogen Distribution in Chinese Hospitalized AECOPD Patients: A Multicenter Cross-Sectional Study

References

• Lõpez-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. doi:10.1111/resp.12660
   PubMed Web of Science ®Google Scholar
• Aaron SD, Vandemheen KL, Clinch JJ, et al. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest. 2002;121(3):688–696. doi:10.1378/chest.121.3.688
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Má MG, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527
   PubMed Web of Science ®Google Scholar
• Mackay AJ, Hurst JR. COPD exacerbations. causes, prevention, and treatment. Immunol Allergy Clin North Am. 2013;33(1):95–115. doi:10.1016/j.iac.2012.10.006
   PubMed Web of Science ®Google Scholar
• Domenech A, Puig C, Martí S, et al. Infectious etiology of acute exacerbations insevere COPD patients. J Infect. 2013;67(6):516–523. doi:10.1016/j.jinf.2013.09.003
   PubMed Web of Science ®Google Scholar
• Nakou A, Papaparaskevas J, Diamantea F, Skarmoutsou N, Polychronopoulos V, Tsakris A. A prospective study on bacterial and atypical etiology of acute exacerbation in chronic obstructive pulmonary disease. Future Microbiol. 2014;9(11):1251–1260. doi:10.2217/fmb.14.90
   PubMed Web of Science ®Google Scholar
• Jung CY, Choe YH, Lee SY, et al. Use of serology and polymerase chain reaction to detect atypical respiratory pathogens during acute exacerbation of chronic obstructive pulmonary disease. Korean J Intern Med. 2018;33(5):941–951. doi:10.3904/kjim.2017.279
   PubMed Web of Science ®Google Scholar
• Aubert G, Pozzetto B, Gaudin OG, Hafid J, Mbida AD, Ros A. Evaluation of five commercial tests: complement fixation, microparticle agglutination, indirect immunofluorescence, enzyme-linked immunosorbent assay and latex agglutination, in comparison to immunoblotting for Mycoplasma pneumoniae serology. Ann Biol Clin. 1992;50(8):593–597. doi:10.1007/s00429-002-0246-9
   PubMed Web of Science ®Google Scholar
• Diederen BMW, Kluytmans JAJW, Peeters MF. Evaluation of Vircell enzyme-linked immunosorbent assay and indirect immunofluorescence assay for detection of antibodies against Legionella pneumophila. Clin Vaccine Immunol. 2006;13(3):361–364. doi:10.1128/CVI.13.3.361-364.2006
   PubMedGoogle Scholar
• Montagnani F, Rossetti B, Vannoni A, Cusi MG, De Luca A. Laboratory diagnosis of Mycoplasma pneumoniae infections: data analysis from clinical practice. New Microbiol. 2018;41(3):203–207.
   PubMed Web of Science ®Google Scholar
• Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017;30(3):747–809. doi:10.1128/CMR.00114-16
   PubMed Web of Science ®Google Scholar
• Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32(6):956–973. doi:10.1111/j.1574-6976.2008.00129.x
   PubMed Web of Science ®Google Scholar
• File T, Bartlett J, Cassell G, et al. The importance of Chlamydia pneumoniae as a pathogen: the 1996 consensus conference on Chlamydia pneumoniae infections. Infect Dis Clin Pract. 1997;6(2):S28–S31. doi:10.3109/15412555.2011.636407
   Web of Science ®Google Scholar
• Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990;161(4):618–625. doi:10.1093/infdis/161.4.618
   PubMed Web of Science ®Google Scholar
• Al-Aydie SN, Obeidat NM, Al-Younes HM. Role of chlamydia pneumoniae in community-acquired pneumonia in hospitalized Jordanian adults. J Infect Dev Ctries. 2016;10(3):227–236. doi:10.3855/jidc.6590
   PubMed Web of Science ®Google Scholar
• Benitez AJ, Thurman KA, Diaz MH, Conklin L, Kendig NE, Winchell JM. Comparison of real-time PCR and a microimmunofluorescence serological assay for detection of Chlamydophila pneumoniae infection in an outbreak investigation. J Clin Microbiol. 2012;50(1):151–153. doi:10.1128/JCM.05357-11
   PubMed Web of Science ®Google Scholar
• Gunasekaran K, Ahmad M, Rehman S, Thilagar B. Impact of a positive viral polymerase chain reaction on outcomes of chronic obstructive pulmonary disease (COPD) exacerbations. Int J Environ Res Public Health. 2020;17:8072. doi:10.3390/ijerph17218072
   PubMed Web of Science ®Google Scholar
• Mercante JW, Winchell JM. Current and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microbiol Rev. 2015;28(1):95–133. doi:10.1128/CMR.00029-14
   PubMed Web of Science ®Google Scholar
• Gao CH, Ji BJ, Han C, Wang MS. Comparison of enzyme-linked immunosorbent assay with indirect immunofluorescence assay for the diagnosis of Mycoplasma pneumoniae infection. J Clin Lab Anal. 2019;33(2):e22677. doi:10.1002/jcla.22677
   PubMed Web of Science ®Google Scholar
• Qu J, Gu L, Wu J, et al. Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC Infect Dis. 2013;13:172. doi:10.1186/1471-2334-13-172
   PubMed Web of Science ®Google Scholar
• Kashyap B, Kumar S, Sethi GR, Das BC, Saigal SR. Comparison of PCR, culture & serological tests for the diagnosis of Mycoplasma pneumoniae in community-acquired lower respiratory tract infections in children. Indian J Med Res. 2008;128(2):134–139. doi:10.1128/JCM.37.1.14-17.1999
   PubMed Web of Science ®Google Scholar
• Shimizu K, Yoshii Y, Morozumi M, et al. Pathogens in COPD exacerbations identified by comprehensive real-time PCR plus older methods. Int J COPD. 2015;10(1):2009–2016. doi:10.2147/COPD.S82752
   Google Scholar
• Wagner K, Springer B, Imkamp F, Opota O, Greub G, Keller PM. Detection of respiratory bacterial pathogens causing atypical pneumonia by multiplex Lightmix® RT-PCR. Int J Med Microbiol. 2018;308(3):317–323. doi:10.1016/j.ijmm.2018.01.010
   PubMed Web of Science ®Google Scholar
• Wagner K, Imkamp F, Pires VP, Keller PM. Evaluation of Lightmix Mycoplasma macrolide assay for detection of macrolide-resistant Mycoplasma pneumoniae in pneumonia patients. Clin Microbiol Infect. 2019;25(3):383.e5–383.e7. doi:10.1016/j.cmi.2018.10.006
   PubMed Web of Science ®Google Scholar
• Orozco-Hoyos N, Baena A, Montoya-Ruiz C, Sánchez GI, Restrepo E. Prevalencia de Chlamydia trachomatis en la población femeninaasintomáticaatendidaen los servicios de citología cervical de tresinstitucionesprestadoras de servicios de saluden Medellín, Colombia. Biomédica. 2020;40(3):534–545. doi:10.7705/biomedica.5225
   PubMedGoogle Scholar
• Nilsson AC, Björkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol. 2008;8:93. doi:10.1186/1471-2180-8-93
   PubMed Web of Science ®Google Scholar
• Diederen BMW, van der Valk PD, Kluytmans JA, Peeters MF, Hendrix R. The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007;30(2):240–244. doi:10.1183/09031936.00012707
   PubMed Web of Science ®Google Scholar
• Boixeda R, Rabella N, Sauca G, et al. Microbiological study of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and the usefulness of analytical and clinical parameters in its identification (VIRAE study). Int J Chron Obstruct Pulmon Dis. 2012;7:327–335. doi:10.2147/copd.s30568
   PubMed Web of Science ®Google Scholar
• Arnold FW, Summersgill JT, Lajoie AS, et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007;175(10):1086–1093. doi:10.1164/rccm.200603-350OC
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Supplement 2):S27–S72. doi:10.1086/511159
   PubMedGoogle Scholar
• Lieberman D, Ben-Yaakov M, Lazarovich Z, Ohana B, Boldur I. Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: analysis of 250 hospitalizations. Eur J Clin Microbiol Infect Dis. 2001;20(10):698–704. doi:10.1007/s100960100596
   PubMed Web of Science ®Google Scholar
• Seemungal T, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(9):1618–1623. doi:10.1164/ajrccm.164.9.2105011
   PubMed Web of Science ®Google Scholar
• Messous S, Trabelsi I, Grissa MH, Nouira S, Pozzetto B, Mastouri M. Prevalence of Chlamydophila pneumoniae and Mycoplasma pneumoniae IgM and IgG antibodies in Tunisian patients presenting with exacerbation of chronic obstructive pulmonary disease. Médecine Mal Infect. 2017;47(2):158–163. doi:10.1016/j.medmal.2016.12.002
   PubMed Web of Science ®Google Scholar
• Meloni F, Paschetto E, Mangiarotti P, et al. Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations. J Chemother. 2004;16(1):70–76. doi:10.1179/joc.2004.16.1.70
   PubMed Web of Science ®Google Scholar
• Varma-Basil M, Dwivedi SKD, Kumar K, et al. Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease. J Med Microbiol. 2009;58(3):322–326. doi:10.1099/jmm.0.003335-0
   PubMed Web of Science ®Google Scholar
• White AJ, Gompertz S, Stockley RA. Chronic obstructive pulmonary disease. 6: the aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax. 2003;58(1):73–80. doi:10.1136/thorax.58.1.73
   PubMed Web of Science ®Google Scholar
• Karnak D, Bengsun S, Beder S, Kayacan O. Chlamydia pneumoniae infection and acute exacerbation of chronic obstructive pulmonary disease (COPD). Respir Med. 2001;95(10):811–816. doi:10.1053/rmed.2001.1159
   PubMed Web of Science ®Google Scholar
• Seemungal TAR, Wedzicha JA, MacCallum PK, Johnston SL, Lambert PA. Chlamydia pneumoniae and COPD exacerbation. Thorax. 2002;57(12):1087–1088. doi:10.1136/thorax.57.12.1087-a
   PubMed Web of Science ®Google Scholar
• Hutchinson AF, Ghimire AK, Thompson MA, et al. A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD. Respir Med. 2007;101(12):2472–2481. doi:10.1016/j.rmed.2007.07.015
   PubMed Web of Science ®Google Scholar
• Lieberman D, Lieberman D, Shmarkov O, et al. Serological evidence of Legionella species infection in acute exacerbation of COPD. Eur Respir J. 2002;19(3):392–397. doi:10.1183/09031936.02.02042002
   PubMed Web of Science ®Google Scholar
• Brightling C, Greening N. Airway inflammation in COPD: progress to precision medicine. Eur Respir J. 2019;54(2):1900651. doi:10.1183/13993003.00651-2019
   PubMed Web of Science ®Google Scholar